MAIA BIOTECHNOLOGY, INC.
MAIACIK 0001878313
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$25.14M
+3.7% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.75
+33.3% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$0
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
60.8M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.